Sp559

NUTRITION, OBESITY, AND EATING DISORDERS

Date
May 19, 2024

Presenter

Speaker Image for Octavia Pickett-Blakely
University of Pennsylvania

Tracks

Related Products

Thumbnail for INCIDENCE PROPORTION OF PANCREATIC COMPLICATIONS WITH INCRETIN-BASED THERAPIES: A MULTICENTER POPULATION-BASED STUDY
INCIDENCE PROPORTION OF PANCREATIC COMPLICATIONS WITH INCRETIN-BASED THERAPIES: A MULTICENTER POPULATION-BASED STUDY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Thumbnail for NUTRITION, OBESITY AND EATING DISORDERS
NUTRITION, OBESITY AND EATING DISORDERS
The AGA Board Review Course held annually at DDW provides attendees with the information they need to stay current in their practice and prepare for both the ABIM recertification and initial certification exams in gastroenterology…
Thumbnail for OUTCOMES ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USE IN PATIENTS UNDERGOING OUTPATIENT UPPER ENDOSCOPY
OUTCOMES ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USE IN PATIENTS UNDERGOING OUTPATIENT UPPER ENDOSCOPY
BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP1RAs) are associated with delayed gastric emptying, which has raised concerns regarding the risk of adverse anesthesia events (e.g., aspiration) among GLP1RA-treated patients…